| Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients S Georgin‐Lavialle, B Terrier, AF Guedon, M Heiblig, T Comont, E Lazaro, ... British Journal of Dermatology 186 (3), 564-574, 2022 | 212 | 2022 |
| Therapeutic options in VEXAS syndrome: insights from a retrospective series E Bourbon, M Heiblig, M Gerfaud Valentin, T Barba, CA Durel, JC Lega, ... Blood, The Journal of the American Society of Hematology 137 (26), 3682-3684, 2021 | 189 | 2021 |
| Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients K Ahmad, T Barba, D Gamondes, M Ginoux, C Khouatra, P Spagnolo, ... Respiratory medicine 123, 56-62, 2017 | 153 | 2017 |
| Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants A Koenig, CC Chen, A Marçais, T Barba, V Mathias, A Sicard, M Rabeyrin, ... Nature Communications 10 (1), 5350, 2019 | 115 | 2019 |
| Treatment of idiopathic inflammatory myositis associated interstitial lung disease: a systematic review and meta-analysis T Barba, R Fort, V Cottin, S Provencher, I Durieu, S Jardel, A Hot, ... Autoimmunity reviews 18 (2), 113-122, 2019 | 113 | 2019 |
| Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study M Heiblig, MA Ferrada, MT Koster, T Barba, M Gerfaud-Valentin, ... Blood, The Journal of the American Society of Hematology 140 (8), 927-931, 2022 | 108 | 2022 |
| IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT) O Thaunat, C Legeai, D Anglicheau, L Couzi, G Blancho, M Hazzan, ... Kidney international 98 (6), 1568-1577, 2020 | 86 | 2020 |
| VEXAS syndrome in a woman T Barba, Y Jamilloux, CA Durel, E Bourbon, F Mestrallet, P Sujobert, A Hot Rheumatology 60 (11), e402-e403, 2021 | 82 | 2021 |
| A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis M Espi, X Charmetant, T Barba, C Mathieu, C Pelletier, L Koppe, ... Kidney international 101 (2), 390-402, 2022 | 72 | 2022 |
| The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis M Espi, X Charmetant, T Barba, L Koppe, C Pelletier, E Kalbacher, ... Kidney international 100 (4), 928-936, 2021 | 66 | 2021 |
| Hemophagocytic lymphohistiocytosis in intensive care unit: a 71-case strobe-compliant retrospective study T Barba, D Maucort-Boulch, J Iwaz, J Bohé, J Ninet, A Hot, JC Lega, ... Medicine 94 (51), e2318, 2015 | 59 | 2015 |
| Missing self-induced activation of NK cells combines with non-complement-fixing donor-specific antibodies to accelerate kidney transplant loss in chronic antibody-mediated … A Koenig, S Mezaache, J Callemeyn, T Barba, V Mathias, A Sicard, ... Journal of the American Society of Nephrology 32 (2), 479-494, 2021 | 57 | 2021 |
| CD4+ T cell help is mandatory for naive and memory donor-specific antibody responses: impact of therapeutic immunosuppression CC Chen, A Koenig, C Saison, S Dahdal, G Rigault, T Barba, M Taillardet, ... Frontiers in immunology 9, 275, 2018 | 53 | 2018 |
| Lung diseases in inflammatory myopathies T Barba, S Mainbourg, M Nasser, JC Lega, V Cottin Seminars in Respiratory and Critical Care Medicine 40 (02), 255-270, 2019 | 38 | 2019 |
| Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) M Papo, RA Sinico, V Teixeira, N Venhoff, ML Urban, M Iudici, J Mahrhold, ... Rheumatology 60 (9), 4355-4360, 2021 | 32 | 2021 |
| Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine X Charmetant, M Espi, T Barba, A Ovize, E Morelon, C Mathieu, ... American Journal of Transplantation 22 (5), 1442-1450, 2022 | 20 | 2022 |
| Interleukine-1, inflammasome et maladies auto-inflammatoires Y Jamilloux, E Bourdonnay, M Gerfaud-Valentin, BF Py, L Lefeuvre, ... La Revue de Médecine Interne 39 (4), 233-239, 2018 | 20 | 2018 |
| Justification, safety, and efficacy of a third dose of mRNA vaccine in maintenance hemodialysis patients: a prospective observational study M Espi, X Charmetant, T Barba, C Pelletier, L Koppe, E Chalencon, ... MedRxiv, 2021.07. 02.21259913, 2021 | 19 | 2021 |
| Highly variable sialylation status of donor-specific antibodies does not impact humoral rejection outcomes T Barba, J Harb, S Ducreux, A Koenig, V Mathias, M Rabeyrin, ... Frontiers in Immunology 10, 513, 2019 | 15 | 2019 |
| Circulating donor-specific anti-HLA antibodies associate with immune activation independent of kidney transplant histopathological findings E Van Loon, B Lamarthée, T Barba, S Claes, M Coemans, H de Loor, ... Frontiers in immunology 13, 818569, 2022 | 14 | 2022 |
